Latest news with #EZZLifeScience
Yahoo
4 hours ago
- Business
- Yahoo
American Rare Earths Leads ASX Penny Stocks To Consider
As the Australian market experiences a gradual decline, influenced by profit-taking and external geopolitical tensions, investors are seeking opportunities beyond traditional large-cap stocks. Penny stocks, though an older term, continue to attract attention for their potential to offer surprising value and growth at lower price points. By focusing on companies with strong balance sheets and solid fundamentals, investors may uncover hidden gems that provide upside without many of the risks typically associated with this segment of the market. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$70.76M ★★★★★★ GTN (ASX:GTN) A$0.65 A$124.05M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$441.56M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$725.72M ★★★★★☆ Regal Partners (ASX:RPL) A$2.25 A$756.37M ★★★★★★ Accent Group (ASX:AX1) A$1.845 A$1.11B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.37 A$159.91M ★★★★★★ CTI Logistics (ASX:CLX) A$1.815 A$146.19M ★★★★☆☆ Click here to see the full list of 1,001 stocks from our ASX Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: American Rare Earths Limited focuses on the exploration and development of mineral resources in Australia and the United States, with a market cap of A$139.54 million. Operations: American Rare Earths Limited currently does not report any revenue segments. Market Cap: A$139.54M American Rare Earths Limited, with a market cap of A$139.54 million, is pre-revenue and debt-free, focusing on the exploration of mineral resources in Australia and the U.S. Recent developments include significant progress at their Cowboy State Mine in Wyoming, where groundwater monitoring wells have been installed as part of environmental permitting efforts. The company also reported promising assay results from its Halleck Creek project, highlighting elevated rare earth mineralization. Leadership changes have strengthened its executive team with seasoned professionals to advance its U.S.-based strategy for developing a secure critical minerals supply chain. Click here to discover the nuances of American Rare Earths with our detailed analytical financial health report. Learn about American Rare Earths' historical performance here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Horizon Gold Limited is involved in the exploration, evaluation, development, and production of gold deposits in Australia with a market cap of A$86.90 million. Operations: The company's revenue segment consists of A$0.08 million from exploration activities in Australia. Market Cap: A$86.9M Horizon Gold Limited, with a market cap of A$86.90 million, is pre-revenue and debt-free, focusing on gold exploration in Australia. The company recently reported a small net income for the half-year ended December 31, 2024, marking an improvement from the previous year's loss. Its management team is experienced with an average tenure of 4.5 years and has seen leadership changes to bolster corporate development efforts as it progresses through the Gum Creek Feasibility Study. While its short-term assets cover liabilities, long-term liabilities remain uncovered by current assets. Shareholder dilution has been minimal over the past year. Unlock comprehensive insights into our analysis of Horizon Gold stock in this financial health report. Gain insights into Horizon Gold's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Ltd is an online retailer based in Australia with a market capitalization of A$401.23 million. Operations: The company's revenue is derived from its operations in Australia, with A$309.36 million from Kogan Parent and A$9.96 million from Mighty Ape, as well as in New Zealand, where it generates A$40.02 million from Kogan Parent and A$124.88 million from Mighty Ape. Market Cap: A$401.23M with a market cap of A$401.23 million, is debt-free and has extended its buyback plan duration until May 2026. Despite stable weekly volatility over the past year, Kogan faces challenges with negative earnings growth of -73.9% last year and declining profit margins from 1.4% to 0.4%. Its dividend yield of 3.47% isn't well covered by earnings, yet the company trades at a substantial discount to estimated fair value. The seasoned management team averages a tenure of 14.6 years, while short-term assets comfortably cover both short- and long-term liabilities without shareholder dilution in the past year. Click here and access our complete financial health analysis report to understand the dynamics of Learn about future growth trajectory here. Unlock more gems! Our ASX Penny Stocks screener has unearthed 998 more companies for you to here to unveil our expertly curated list of 1,001 ASX Penny Stocks. Want To Explore Some Alternatives? These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ARR ASX:HRN and ASX:KGN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Business
- Yahoo
American Rare Earths Leads ASX Penny Stocks To Consider
As the Australian market experiences a gradual decline, influenced by profit-taking and external geopolitical tensions, investors are seeking opportunities beyond traditional large-cap stocks. Penny stocks, though an older term, continue to attract attention for their potential to offer surprising value and growth at lower price points. By focusing on companies with strong balance sheets and solid fundamentals, investors may uncover hidden gems that provide upside without many of the risks typically associated with this segment of the market. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$70.76M ★★★★★★ GTN (ASX:GTN) A$0.65 A$124.05M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$441.56M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$725.72M ★★★★★☆ Regal Partners (ASX:RPL) A$2.25 A$756.37M ★★★★★★ Accent Group (ASX:AX1) A$1.845 A$1.11B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.37 A$159.91M ★★★★★★ CTI Logistics (ASX:CLX) A$1.815 A$146.19M ★★★★☆☆ Click here to see the full list of 1,001 stocks from our ASX Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: American Rare Earths Limited focuses on the exploration and development of mineral resources in Australia and the United States, with a market cap of A$139.54 million. Operations: American Rare Earths Limited currently does not report any revenue segments. Market Cap: A$139.54M American Rare Earths Limited, with a market cap of A$139.54 million, is pre-revenue and debt-free, focusing on the exploration of mineral resources in Australia and the U.S. Recent developments include significant progress at their Cowboy State Mine in Wyoming, where groundwater monitoring wells have been installed as part of environmental permitting efforts. The company also reported promising assay results from its Halleck Creek project, highlighting elevated rare earth mineralization. Leadership changes have strengthened its executive team with seasoned professionals to advance its U.S.-based strategy for developing a secure critical minerals supply chain. Click here to discover the nuances of American Rare Earths with our detailed analytical financial health report. Learn about American Rare Earths' historical performance here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Horizon Gold Limited is involved in the exploration, evaluation, development, and production of gold deposits in Australia with a market cap of A$86.90 million. Operations: The company's revenue segment consists of A$0.08 million from exploration activities in Australia. Market Cap: A$86.9M Horizon Gold Limited, with a market cap of A$86.90 million, is pre-revenue and debt-free, focusing on gold exploration in Australia. The company recently reported a small net income for the half-year ended December 31, 2024, marking an improvement from the previous year's loss. Its management team is experienced with an average tenure of 4.5 years and has seen leadership changes to bolster corporate development efforts as it progresses through the Gum Creek Feasibility Study. While its short-term assets cover liabilities, long-term liabilities remain uncovered by current assets. Shareholder dilution has been minimal over the past year. Unlock comprehensive insights into our analysis of Horizon Gold stock in this financial health report. Gain insights into Horizon Gold's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Ltd is an online retailer based in Australia with a market capitalization of A$401.23 million. Operations: The company's revenue is derived from its operations in Australia, with A$309.36 million from Kogan Parent and A$9.96 million from Mighty Ape, as well as in New Zealand, where it generates A$40.02 million from Kogan Parent and A$124.88 million from Mighty Ape. Market Cap: A$401.23M with a market cap of A$401.23 million, is debt-free and has extended its buyback plan duration until May 2026. Despite stable weekly volatility over the past year, Kogan faces challenges with negative earnings growth of -73.9% last year and declining profit margins from 1.4% to 0.4%. Its dividend yield of 3.47% isn't well covered by earnings, yet the company trades at a substantial discount to estimated fair value. The seasoned management team averages a tenure of 14.6 years, while short-term assets comfortably cover both short- and long-term liabilities without shareholder dilution in the past year. Click here and access our complete financial health analysis report to understand the dynamics of Learn about future growth trajectory here. Unlock more gems! Our ASX Penny Stocks screener has unearthed 998 more companies for you to here to unveil our expertly curated list of 1,001 ASX Penny Stocks. Want To Explore Some Alternatives? These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ARR ASX:HRN and ASX:KGN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 hours ago
- Business
- Yahoo
ASX Penny Stocks Spotlight Australian Strategic Materials And 2 More Hidden Gems
As the Australian market experiences a gradual downward trend, largely influenced by profit-taking and international tensions, investors are seeking opportunities that can withstand volatility. Penny stocks, though often considered niche investments, still hold potential for growth particularly in smaller or newer companies. When these stocks are backed by solid financial health and fundamentals, they can present underappreciated opportunities for returns without excessive risk. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$70.76M ★★★★★★ GTN (ASX:GTN) A$0.65 A$124.05M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$441.56M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$725.72M ★★★★★☆ Regal Partners (ASX:RPL) A$2.25 A$756.37M ★★★★★★ Accent Group (ASX:AX1) A$1.845 A$1.11B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.37 A$159.91M ★★★★★★ CTI Logistics (ASX:CLX) A$1.815 A$146.19M ★★★★☆☆ Click here to see the full list of 1,001 stocks from our ASX Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Australian Strategic Materials Ltd is an integrated producer of critical metals for advanced and clean technologies in Australia, with a market cap of A$116.96 million. Operations: The company's revenue is primarily derived from its operations in Korea, generating A$0.91 million, and the Dubbo Project, contributing A$1.12 million. Market Cap: A$116.96M Australian Strategic Materials Ltd is pre-revenue, with limited sales of A$1.13 million reported for the half year ending December 2024, and a net loss of A$13.96 million. Despite its unprofitability, ASM has reduced its debt to equity ratio significantly over five years from 319.6% to 8.6%, indicating improved financial management. The company has more cash than total debt and short-term assets exceeding both short- and long-term liabilities, suggesting a stable financial position despite high volatility in share price and less than one year of cash runway based on current free cash flow trends. Click to explore a detailed breakdown of our findings in Australian Strategic Materials' financial health report. Review our historical performance report to gain insights into Australian Strategic Materials' track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Horizon Oil Limited, with a market cap of A$292.55 million, is involved in the exploration, development, and production of oil and gas properties across China, New Zealand, and Australia. Operations: The company's revenue segments include $60.53 million from exploration and development activities in China and $34.26 million from similar operations in New Zealand. Market Cap: A$292.55M Horizon Oil Limited, with a market cap of A$292.55 million, has demonstrated financial resilience despite recent challenges. The company maintains more cash than its total debt, and its interest payments are well-covered by EBIT at 60.8 times coverage. However, Horizon's dividend yield of 15.3% is not supported by earnings or free cash flow, raising sustainability concerns. Profit margins have decreased to 14.1% from last year's 30.3%, and the company experienced negative earnings growth over the past year (-67%). Recent board changes include appointing Catherine Costello as an independent non-executive director to strengthen governance and strategic oversight. Click here and access our complete financial health analysis report to understand the dynamics of Horizon Oil. Explore historical data to track Horizon Oil's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: SHAPE Australia Corporation Limited operates in the construction, fitout, and refurbishment of commercial properties across Australia with a market cap of A$287.93 million. Operations: The company's revenue is primarily derived from its heavy construction segment, which generated A$902.63 million. Market Cap: A$287.93M SHAPE Australia Corporation Limited, with a market cap of A$287.93 million, has shown robust financial performance in the construction sector. Despite an unstable dividend track record, its earnings have grown significantly by 34.9% over the past year, surpassing both industry averages and its 5-year growth rate of 9.3% per annum. The company is debt-free and efficiently manages liabilities with short-term assets of A$209.5 million exceeding both short-term and long-term obligations. SHAPE's Return on Equity stands at an impressive 54.2%, indicating high-quality earnings and effective use of equity capital, although management tenure data remains insufficient for assessment. Jump into the full analysis health report here for a deeper understanding of SHAPE Australia. Explore SHAPE Australia's analyst forecasts in our growth report. Click here to access our complete index of 1,001 ASX Penny Stocks. Ready To Venture Into Other Investment Styles? Outshine the giants: these 25 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ASM ASX:HZN and ASX:SHA. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
12 hours ago
- Business
- Yahoo
ASX Penny Stocks Spotlight Australian Strategic Materials And 2 More Hidden Gems
As the Australian market experiences a gradual downward trend, largely influenced by profit-taking and international tensions, investors are seeking opportunities that can withstand volatility. Penny stocks, though often considered niche investments, still hold potential for growth particularly in smaller or newer companies. When these stocks are backed by solid financial health and fundamentals, they can present underappreciated opportunities for returns without excessive risk. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$70.76M ★★★★★★ GTN (ASX:GTN) A$0.65 A$124.05M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$441.56M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$725.72M ★★★★★☆ Regal Partners (ASX:RPL) A$2.25 A$756.37M ★★★★★★ Accent Group (ASX:AX1) A$1.845 A$1.11B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.37 A$159.91M ★★★★★★ CTI Logistics (ASX:CLX) A$1.815 A$146.19M ★★★★☆☆ Click here to see the full list of 1,001 stocks from our ASX Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Australian Strategic Materials Ltd is an integrated producer of critical metals for advanced and clean technologies in Australia, with a market cap of A$116.96 million. Operations: The company's revenue is primarily derived from its operations in Korea, generating A$0.91 million, and the Dubbo Project, contributing A$1.12 million. Market Cap: A$116.96M Australian Strategic Materials Ltd is pre-revenue, with limited sales of A$1.13 million reported for the half year ending December 2024, and a net loss of A$13.96 million. Despite its unprofitability, ASM has reduced its debt to equity ratio significantly over five years from 319.6% to 8.6%, indicating improved financial management. The company has more cash than total debt and short-term assets exceeding both short- and long-term liabilities, suggesting a stable financial position despite high volatility in share price and less than one year of cash runway based on current free cash flow trends. Click to explore a detailed breakdown of our findings in Australian Strategic Materials' financial health report. Review our historical performance report to gain insights into Australian Strategic Materials' track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Horizon Oil Limited, with a market cap of A$292.55 million, is involved in the exploration, development, and production of oil and gas properties across China, New Zealand, and Australia. Operations: The company's revenue segments include $60.53 million from exploration and development activities in China and $34.26 million from similar operations in New Zealand. Market Cap: A$292.55M Horizon Oil Limited, with a market cap of A$292.55 million, has demonstrated financial resilience despite recent challenges. The company maintains more cash than its total debt, and its interest payments are well-covered by EBIT at 60.8 times coverage. However, Horizon's dividend yield of 15.3% is not supported by earnings or free cash flow, raising sustainability concerns. Profit margins have decreased to 14.1% from last year's 30.3%, and the company experienced negative earnings growth over the past year (-67%). Recent board changes include appointing Catherine Costello as an independent non-executive director to strengthen governance and strategic oversight. Click here and access our complete financial health analysis report to understand the dynamics of Horizon Oil. Explore historical data to track Horizon Oil's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: SHAPE Australia Corporation Limited operates in the construction, fitout, and refurbishment of commercial properties across Australia with a market cap of A$287.93 million. Operations: The company's revenue is primarily derived from its heavy construction segment, which generated A$902.63 million. Market Cap: A$287.93M SHAPE Australia Corporation Limited, with a market cap of A$287.93 million, has shown robust financial performance in the construction sector. Despite an unstable dividend track record, its earnings have grown significantly by 34.9% over the past year, surpassing both industry averages and its 5-year growth rate of 9.3% per annum. The company is debt-free and efficiently manages liabilities with short-term assets of A$209.5 million exceeding both short-term and long-term obligations. SHAPE's Return on Equity stands at an impressive 54.2%, indicating high-quality earnings and effective use of equity capital, although management tenure data remains insufficient for assessment. Jump into the full analysis health report here for a deeper understanding of SHAPE Australia. Explore SHAPE Australia's analyst forecasts in our growth report. Click here to access our complete index of 1,001 ASX Penny Stocks. Ready To Venture Into Other Investment Styles? Outshine the giants: these 25 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ASM ASX:HZN and ASX:SHA. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
01-06-2025
- Business
- Yahoo
ASX Penny Stocks To Consider In June 2025
The Australian market is experiencing some turbulence, with futures indicating a slight decline for the ASX 200, largely influenced by ongoing international trade uncertainties. Despite these fluctuations, investors continue to seek opportunities in various sectors, including the often-overlooked realm of penny stocks. Although the term 'penny stocks' might seem outdated, these smaller or newer companies can offer unique opportunities for growth and value when supported by solid financials. Name Share Price Market Cap Financial Health Rating Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ CTI Logistics (ASX:CLX) A$1.85 A$149.01M ★★★★☆☆ Accent Group (ASX:AX1) A$1.90 A$1.14B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.565 A$73.83M ★★★★★★ IVE Group (ASX:IGL) A$2.55 A$393.16M ★★★★★☆ GTN (ASX:GTN) A$0.61 A$116.42M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.50 A$166.08M ★★★★★★ Regal Partners (ASX:RPL) A$2.33 A$783.26M ★★★★★★ Tasmea (ASX:TEA) A$2.99 A$699.78M ★★★★★☆ SHAPE Australia (ASX:SHA) A$3.29 A$272.21M ★★★★★★ Click here to see the full list of 1,000 stocks from our ASX Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix technology in the United States and internationally, with a market cap of A$175.90 million. Operations: Revenue Segments: No specific revenue segments have been reported for Aroa Biosurgery Limited. Market Cap: A$175.9M Aroa Biosurgery has demonstrated notable progress, with sales reaching NZ$84.7 million for the year ending March 31, 2025, reflecting an increase from the previous year. Despite a net loss of NZ$3.81 million, this marks an improvement from prior losses. The company is debt-free and maintains a strong cash position with short-term assets surpassing liabilities significantly, ensuring a stable financial runway for over three years. Recent clinical evidence highlights the efficacy of its Endoform Natural product in treating venous leg ulcers more effectively than competitors, potentially enhancing patient outcomes and reducing costs in wound care management. Click to explore a detailed breakdown of our findings in Aroa Biosurgery's financial health report. Examine Aroa Biosurgery's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Baby Bunting Group Limited operates as a retailer of maternity and baby goods in Australia and New Zealand, with a market cap of A$233.41 million. Operations: The company generates A$496.90 million in revenue from its specialty retail segment. Market Cap: A$233.41M Baby Bunting Group's financial position is mixed, with a market cap of A$233.41 million and revenue of A$496.90 million from its specialty retail segment. The company faces challenges, such as negative earnings growth over the past year and declining profit margins, currently at 1.2%. Despite these issues, Baby Bunting maintains a satisfactory net debt to equity ratio of 8.6%, with debt well covered by operating cash flow at 177.9%. However, short-term assets do not cover long-term liabilities (A$132 million), and interest coverage by EBIT is low at 2.2x, indicating potential financial strain ahead. Jump into the full analysis health report here for a deeper understanding of Baby Bunting Group. Explore Baby Bunting Group's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: COSOL Limited, along with its subsidiaries, offers information technology services across the Asia Pacific, North America, Europe, the Middle East, Africa, and globally with a market cap of A$142.86 million. Operations: The company generates revenue primarily from its Asia Pacific operations, contributing A$98.75 million, and North American activities, adding A$12.26 million. Market Cap: A$142.86M COSOL Limited, with a market cap of A$142.86 million, demonstrates mixed financial health. Trading at a value price-to-earnings ratio of 16x and offering high-quality earnings, it presents potential value compared to peers. However, its short-term assets (A$32.3M) do not cover long-term liabilities (A$40.7M), and net profit margins have declined from 9.5% to 8.1%. The company's debt is well covered by operating cash flow at 25%, but the dividend yield of 3.04% isn't supported by free cash flows. Recent inclusion in the S&P/ASX All Ordinaries Index highlights its growing recognition in the market. Get an in-depth perspective on COSOL's performance by reading our balance sheet health report here. Gain insights into COSOL's future direction by reviewing our growth report. Reveal the 1,000 hidden gems among our ASX Penny Stocks screener with a single click here. Ready For A Different Approach? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ARX ASX:BBN and ASX:COS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
